Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 6 studies | 39% ± 23% | |
retina horizontal cell | 6 studies | 43% ± 14% | |
oligodendrocyte precursor cell | 5 studies | 42% ± 20% | |
GABAergic neuron | 4 studies | 45% ± 23% | |
neuron | 3 studies | 24% ± 7% | |
fibroblast | 3 studies | 18% ± 2% | |
interneuron | 3 studies | 57% ± 21% | |
oligodendrocyte | 3 studies | 30% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 37% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 1818.02 | 258 / 258 | 87% | 7.46 | 201 / 230 |
brain | 100% | 812.15 | 2633 / 2642 | 57% | 1.80 | 402 / 705 |
prostate | 97% | 633.61 | 237 / 245 | 24% | 0.64 | 120 / 502 |
ovary | 100% | 1372.69 | 180 / 180 | 20% | 0.51 | 87 / 430 |
uterus | 99% | 1257.91 | 168 / 170 | 15% | 0.68 | 69 / 459 |
breast | 97% | 634.63 | 446 / 459 | 13% | 0.23 | 146 / 1118 |
lung | 93% | 387.25 | 537 / 578 | 17% | 0.42 | 199 / 1155 |
bladder | 100% | 415.29 | 21 / 21 | 7% | 0.22 | 37 / 504 |
spleen | 100% | 491.43 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 569.02 | 1174 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 74% | 284.19 | 1075 / 1445 | 20% | 0.65 | 37 / 183 |
thymus | 87% | 283.84 | 569 / 653 | 6% | 0.22 | 35 / 605 |
kidney | 73% | 242.66 | 65 / 89 | 12% | 0.20 | 104 / 901 |
intestine | 78% | 291.53 | 751 / 966 | 5% | 0.12 | 27 / 527 |
heart | 64% | 197.98 | 553 / 861 | 0% | 0 | 0 / 0 |
skin | 46% | 116.05 | 838 / 1809 | 11% | 0.46 | 51 / 472 |
stomach | 47% | 168.30 | 167 / 359 | 9% | 0.30 | 27 / 286 |
blood vessel | 56% | 161.05 | 744 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 15% | 26.69 | 48 / 328 | 28% | 0.47 | 50 / 178 |
muscle | 38% | 75.25 | 306 / 803 | 0% | 0 | 0 / 0 |
liver | 18% | 31.60 | 40 / 226 | 14% | 0.43 | 56 / 406 |
peripheral blood | 9% | 21.11 | 81 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 6% | 0.29 | 5 / 80 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006508 | Biological process | proteolysis |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0008236 | Molecular function | serine-type peptidase activity |
GO_0008239 | Molecular function | dipeptidyl-peptidase activity |
GO_0004180 | Molecular function | carboxypeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0016805 | Molecular function | dipeptidase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004181 | Molecular function | metallocarboxypeptidase activity |
Gene name | NAALAD2 |
Protein name | NAALAD2 protein Alternative protein NAALAD2 N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II) N-acetylated-alpha-linked acidic dipeptidase 2 |
Synonyms | |
Description | FUNCTION: Has N-acetylated-alpha-linked-acidic dipeptidase (NAALADase) activity. Also exhibits a dipeptidyl-peptidase IV type activity. Inactivates the peptide neurotransmitter N-acetylaspartylglutamate. . |
Accessions | ENST00000534061.6 [Q9Y3Q0-1] ENST00000643618.1 ENST00000525171.5 ENST00000375944.7 [Q9Y3Q0-2] E9PJ53 Q9Y3Q0 E9PKX5 ENST00000526637.1 ENST00000642929.1 ENST00000643677.1 ENST00000525497.5 ENST00000647397.2 [Q9Y3Q0-1] ENST00000646420.1 Q4G181 E9PJV2 ENST00000644696.1 [Q9Y3Q0-2] ENST00000527493.5 L8EAF7 J3KNJ3 ENST00000646644.1 ENST00000321955.8 E9PII2 |